References
- Adam D., Naber K. G. Concentrations of ceftriaxone in prostate adenoma tissue. Chemotherapy 1984; 30: 1–6
- Balant L., Dayer P., Auckenthaler R. Clinical pharmacokinetics of the third generation cephalosphoins. Clinical Pharmacokinetics 1985; 10: 101–143
- Bevill R. F., Koritz G. D., Rudawsky G., Dittert L. W., Huang C. H., Hayashi M., Bourne D. W. A. Disposition of sulfadimethoxine in swine: inclusion of protein binding factors in a pharmacokinetic model. Journal of Pharmacokinetics and Biopharmaceutics 1982; 10: 539–550
- Bourne D. W. A., Bialer M., Dittert L. W., Hayashi M., Rudawsky G., Koritz G. D., Bevill R. F. Disposition of sulfadimethoxine in cattle: inclusion of protein binding factors in a pharmacokinetic model. Journal of Pharmaceutical Sciences 1981; 70: 1068–1072
- Bourne D. W. A., Wright A. Modification of the digital computer program NONLIN which allows it to run on the PDP-11 minicomputer. Australian Journal of Pharmaceutical Sciences 1981; 10: 23–24
- Chamberlain J., Coombes J. D., Dell D., Fromson J. M., Ings R. J., Macdonald C. M., McEwen J. Metabolism of cefotaxime in animals and man. Journal of Antimicrobial Chemotheraphy 1980; 6(Suppl. A)69–78
- Hakim L., Bourne D. W. A., Triggs E. J. High performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma. Journal of Chromatography 1988; 424: 111–117
- Hakim L., Bourne D. W. A., Triggs E. J. Disposition of cefotaxime and its metabolite, desacetylcefotaxime, in rat: application of a pharmacokinetic-protein binding model. Xenobiotica 1989; 19: 743–754
- Hulse M., Feldman S., Bruckner J. V. Effect of blood sampling schedules on protein drug binding in the rat. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 416–420
- Reeves D. S., White L. O., Holt H. A., Bahari D., Bywater M. J., Bax R. P. Human metabolism of cefotaxime. Journal of Antimicrobial Chemotherapy 1980; 6(Suppl. A)93–101
- Regamey C. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Chemotherapy 1985; 31: 85–94
- Stoeckel K., McNamara P. J., Brandt R., Plozza-Nottebrock H., Ziegler W. H. Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clinical Pharmacology and Therapeutics 1981; 29: 650–657
- Wise R., Brown R. M., Andrews J. M. A comparison of the pharmacokinetics and tissue penetration of four cephalosphorins. Proceedings of the 13th International Congress in Chemotherapy 1983; 4: 100/7–100/10
- Wise R., Wright N., Wills P. J. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease. Antimicrobial Agents and Chemotherapy 1981; 19: 526–531